Total returns on £1000
1Y
- 3M
- 6M
- 1Y
- 3Y
- 5Y
| Fund/benchmark | Change | |
|---|---|---|
| Price | Crystal Amber Fund Limited (Ordinary Share) | +70.27% |
| NAV | Crystal Amber Fund Limited (Ordinary Share) | +47.96% |
| Morningstar's Benchmark | Numis Smaller Companies TR GBP | -- |
- Monthly Net Asset Value
- Total Voting Rights
- Holding(s) in Company
- Transaction in Own Shares and Total Voting Rights
- Director/PDMR Shareholding
- Extension to Share Buyback Programme
- Investee company update: Morphic Medical Inc.
- Morphic Medical – FDA approval of study amendments
- Transaction in Own Shares
- Monthly Net Asset Value
More ▼
Key statistics
As of last trade Crystal Amber Fund Limited (CRS:LSE) traded at 110.40, -3.71% below its 52-week high of 114.65, set on Aug 15, 2024.
52-week range
| Shares outstanding | 71.55m |
|---|---|
| Market cap | 79.42m GBP |
| Total assets | 125.06m GBP |
| Total expense ratio | 1.53% |
| High | 110.40 |
| Low | 108.00 |
| Previous close | 111.00 |
| Average volume | 45.14k |
|---|---|
| YTD Change | +43.38% |
| Beta | 1.4770 |
| Diluted NAV (est) | 174.81 |
| Diluted NAV (last pub) | 174.13 |
| Premium/Discount | -38.22% |
| Net Gearing | 0.00% |
| Annual div (ADY) | -- |
|---|---|
| Annual div yield (ADY) | -- |
| Div ex-date | Jun 15 2023 |
| Div pay-date | Jul 07 2023 |
Data delayed at least 20 minutes, as of Sep 19 2024 08:30 BST.
More ▼
